Atlas Trials

Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors

Clinical trial NCT01341834 · UNKNOWN

Trial details

NCT number
NCT01341834
Sponsor
National Cancer Centre, Singapore
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma, Lymphomas, Any EBV+ Solid Tumour
Start date
2010-03-01
Primary completion
2016-06-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.